Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

Merlin ends drought for Boston tech firms after listing this week on the Nasdaq exchange

Audit committee shortfall puts Lifeward (NASDAQ: LFWD) on Nasdaq non-compliance notice

Co-Diagnostics (NASDAQ: CODX) Expands CoSara Distribution Territory Across South Asia

High oil prices knock down stocks and erase Wall Street’s hopes for a cut to interest rates

Russell 2000 enters correction territory, and the Dow, S&P 500, and Nasdaq are not far off